Piyush Tiwari Kumar

Centyle Biotech Pvt Ltd, based in India, has emerged as a trailblazer in the field of biotechnology and genomics, becoming the country's first automation-enabled sequencing and multi-omics service provider. With an ambitious mission to advance scientific research and innovation, Centyle integrates cutting-edge genomics, proteomics, and metabolomics analysis on a unified platform, transforming the way biological data is understood and utilized. Their comprehensive range of sequencing services, spanning from Sanger sequencing to next-generation sequencing (NGS) on state-of-the-art platforms, marks them as a pioneering force in India's biotech landscape and across the Asian subcontinent.